Have You Experienced NAION After Taking Semaglutide?

If you or a loved one has experienced severe side effects after taking semaglutide, such as vision loss or other complications, you may be entitled to compensation. Medications like Ozempic®, Wegovy®, and Rybelsus®—all containing semaglutide—have been linked to serious health risks, including vision loss from NAION (non-arteritic anterior ischemic optic neuropathy).

The diabetes drug Ozempic®, in particular, is currently the subject of several lawsuits alleging that its manufacturer, Novo Nordisk, failed to adequately warn consumers about severe side effects. The ongoing legal actions include an Ozempic® class action lawsuit, which consolidates individual claims to address the widespread impact of the drug’s side effects. Napoli Shkolnik is here to help you understand your rights and hold manufacturers accountable.

For more information or for a free, no-risk consultation, contact us today >>

Start Your Free Case Evaluation

Fill out the simple form below.

This field is for validation purposes and should be left unchanged.
Were you prescribed any of the following (please select all that apply):(Required)
Have you been diagnosed with NAION (non-arteritic anterior ischemic optic neuropathy)?(Required)
In which eye has NAION occured?(Required)

What is Semaglutide and How Does it Work?

Semaglutide, sold under brand names such as Ozempic®, Wegovy®, and Rybelsus®, is primarily prescribed to manage Type 2 diabetes by helping control blood sugar levels. Recently, it has gained popularity as a weight loss medication, despite being linked to significant health risks. Semaglutide belongs to the class of drugs known as GLP-1 receptor agonists, which work by slowing digestion and reducing appetite. While effective, these drugs are now associated with severe side effects, prompting a rise in litigation.

Common Semaglutide Side Effects and Health Risks

Despite its intended benefits, semaglutide has been connected to a range of serious complications, including:

NAION (Vision Loss): Some patients taking semaglutide have reported vision loss due to non-arteritic anterior ischemic optic neuropathy, a condition caused by reduced blood flow to the optic nerve.

In addition to these side effects, semaglutide has also been linked to an increased risk of thyroid cancer and medullary thyroid carcinoma. The FDA has received reports of suicidal thoughts and behaviors in patients taking semaglutide, highlighting the need for close monitoring.

It’s essential to note that not everyone who takes semaglutide will experience these side effects, and the risk of developing them may vary depending on individual factors, such as dosage and duration of treatment. However, if you are taking Ozempic® or any other semaglutide medication and experience any of these side effects, it’s crucial to seek medical attention immediately.

For more information or for a free, no-risk consultation, contact us today. 

 

Why File a Lawsuit Against Semaglutide Manufacturers?

Recent lawsuits claim that manufacturers, such as Novo Nordisk, failed to properly warn users about the serious risks of using semaglutide. Individuals who have experienced side effects such as NAION may be eligible for compensation, covering:

  • Medical Expenses: Recover costs for ongoing treatments and healthcare needs.
  • Lost Wages: Receive compensation for missed work due to health complications.
  • Pain and Suffering: Seek damages for the physical and emotional impact of these side effects.

By filing a claim, you’re not only seeking compensation but also raising awareness of the risks associated with these medications.

Start Your Free Legal Assessment
Serious black woman

Why Hold the Manufacturer Novo Nordisk Accountable?

Pharmaceutical companies have a responsibility to ensure their medications are safe for consumers. When they fail to adequately test their products or warn users of potential risks, they must be held accountable. By taking legal action, you can:

  • Seek Compensation: Cover medical expenses, lost wages, and other damages related to your vision problems.
  • Raise Awareness: Help prevent others from suffering similar issues by bringing attention to the risks associated with Ozempic.
  • Promote Safer Practices: Encourage pharmaceutical companies to prioritize safety and transparency in their drug development processes.

Steps to Join the This Lawsuit

If you have experienced vision problems after taking semaglutide, also prescribed as Ozempic or Wegovy, follow these steps to join the lawsuit and seek compensation:

1.

Contact Us: Fill out the form above to schedule a free, no-obligation consultation.

2.

Provide Details: Share your experience with this prescription, including any medical records and documentation of your vision issues.

3.

Legal Evaluation: Our experienced attorneys will evaluate your case and determine the best course of action.

4.

Pursue Justice: We will guide you through the legal process, fighting tirelessly to secure the compensation you deserve.

Request My Free Case Evaluation

Frequently Asked Questions

Studies show that prolonged use of Ozempic may increase the risk of several side effects, but mostly notably NAION for which there is no treatment and most commonly leads to blindness.

Semaglutide is a generic name for Ozempic.

Ozempic is manufactured by Novo Nordisk.

Rybelsus is a daily oral tablet that contains the same medication as the weekly injectable Ozempic.

No, if you are diagnosed with a side effect after taking Ozempic for weight loss, you may still have a claim. 

Award-Winning National Pharmaceutical Litigation Firm

2026 Best Lawyers Medical Malpractice
Best Lawyers® "Best Law Firms" - Product Liability 2024
The nations Trial Lawyers award

DEDICATED

CARING LEGAL TEAM

QUALIFIED

LEGAL KNOWLEDGE AND EXPERTISE

NO FEE

UNLESS YOU WIN YOUR CASE

Copyright © 2026 | All Rights Reserved | Privacy PolicyTerms of Use. Powered by Lemonade Stand.

Napoli Shkolnik is a registered trade name for NSPR Legal Services LLC, A Puerto Rican Limited Liability Corporation.

Attorney Advertising. The information on this website is for general information purposes only. Nothing on this site should be taken as legal advice for any individual case or situation. This information is not intended to create, and receipt or viewing does not constitute, an attorney-client relationship. Past outcomes mentioned on this site do not guarantee future results.

References: 2021 study:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561257/ 4New Study Reveals Chemical In Black Hair Care Products Increases Risk Of Breast Cancer